Aug 29 (Reuters) - Prescient Therapeutics Ltd PTX.AX :
* FY loss for year attributable $2.6 million
* FY revenues from ordinary activities up 1,452.9 pct to $166,220
* FY total revenues $1.2 million versus $1.0 million
Aug 29 (Reuters) - Prescient Therapeutics Ltd PTX.AX :
* FY loss for year attributable $2.6 million
* FY revenues from ordinary activities up 1,452.9 pct to $166,220
* FY total revenues $1.2 million versus $1.0 million